Copyright
©The Author(s) 2024.
World J Hepatol. May 27, 2024; 16(5): 784-790
Published online May 27, 2024. doi: 10.4254/wjh.v16.i5.784
Published online May 27, 2024. doi: 10.4254/wjh.v16.i5.784
Table 1 Baseline characteristics of the cirrhotic and non-cirrhotic cohorts, n (%)/ mean ± SD
| Cirrhosis (16 patients, 19 procedures) | Controls (43 patients, 45 procedures) | P value | |
| Age (yr) | 66.38 ± 8.08 | 64.81 ± 11.50 | 0.57 |
| Gender (male) | 10 (62.50) | 28 (65.12) | 0.85 |
| Race (white) | 14 (87.5) | 33 (76.74) | 0.36 |
| Anticoagulation (yes) | 0 | 7 (15.5) | 0.09 |
| Intraprocedural diameter (mm) | 39.21 ± 13.21 | 43.44 ± 20.49 | 0.34 |
| Fibrosis (yes) | 4 (25) | 14 (31.11) | 0.55 |
| Location of lesion | |||
| Colorectal | 5 (26.32) | 13 (28.89) | 0.83 |
| Stomach | 3 (15.79) | 6 (13.33) | 0.80 |
| Esophagus | 10 (52.63) | 24 (53.33) | 0.96 |
| Duodenum | 1 (5.26) | 2 (4.44) | 0.89 |
| Child Classification | |||
| A | 10 (62.5) | ||
| B | 3 (18.75) | ||
| C | 1 (6.25) | ||
| Unspecified | 2 (12.5) | ||
| Paris IIc (depressed) lesion | 5 (26.32) | 12 (26.67) | 0.98 |
Table 2 Procedural outcomes of cirrhotic and non-cirrhotic cohorts, n (%)
| Cirrhosis (16 patients, 19 procedures) | Controls (43 patients, 45 procedures) | P value | |
| Primary outcomes | |||
| En bloc resection | 16 (84.21) | 40 (88.89) | 0.61 |
| R0 resection | 15 (78.94) | 31 (68.89) | 0.41 |
| Curative resection | 14 (73.68) | 29 (64.44) | 0.47 |
| Procedure duration (mean ± SD; min) | 89.32 ± 40.61 | 97.62 ± 57.3 | 0.52 |
| Follow-up | 10 (52.63) | 19 (42.22) | 0.44 |
| Recurrence | 4 (40) | 1 (5.26) | 0.019 |
| Adverse events | |||
| Any adverse event | 4 (21.05) | 5 (12.5) | 0.30 |
| Surgery for any cause | 2 (10.52) | 4 (9.76) | 0.83 |
| Admitted | 7 (36.84) | 26 (57.78) | 0.13 |
| Pneumoperitoneum/pneumomediastinum | 1 (5.26) | 2 (4.44) | 0.89 |
| Micro-perforation | 0 | 1 (2.22) | 1.00 |
| Delayed bleeding (yes) | 1 (5.26) | 5 (11.11) | 0.46 |
| Procedural characteristics | |||
| Closure (yes) | 12 (63.16) | 21 (46.67) | 0.23 |
| Use of traction (yes) | 1 (5.26) | 3 (6.67) | 0.83 |
| Use of a stabilization device (yes) | 4 (21.05) | 3 (6.67) | 0.09 |
| Use of coagrasper (yes) | 9 (47.37) | 9 (20) | 0.026 |
| Coagrasper use by location | |||
| Colorectal | 3 (60) | 0 | 0.012 |
| Stomach | 2 (66.66) | 2 (33.33) | 0.34 |
| Esophagus | 4 (40) | 7 (29.17) | 0.54 |
| Duodenum | 0 | 0 | |
Table 3 Multivariate regression analysis
| Risk of recurrence at follow up | Odds ratio | Robust standard error | P value | Lower bound of 95%CI | Upper bound of 95%CI |
| Lesion size in mm | 1.03 | 0.19 | 0.103 | 0.99 | 1.06 |
| Cirrhosis | 13.77 | 18.95 | 0.057 | 0.92 | 204.47 |
| Bleeding requiring coagulation grasper use | 0.51 | 0.0.57 | 0.554 | 0.056 | 4.66 |
| Presence of fibrosis | 0.73 | 0.90 | 0.802 | 0.06 | 8.25 |
- Citation: Pecha RL, Ayoub F, Patel A, Muftah A, Wright MW, Khalaf MA, Othman MO. Outcomes of endoscopic submucosal dissection in cirrhotic patients: First American cohort. World J Hepatol 2024; 16(5): 784-790
- URL: https://www.wjgnet.com/1948-5182/full/v16/i5/784.htm
- DOI: https://dx.doi.org/10.4254/wjh.v16.i5.784
